VolitionRx Limited (NYSE:VNRX) Q4 2020 Results Conference Call March 23, 2021 8:00 AM ET Company Participants Scott Powell - Investor Relations Cameron Reynolds - President and Chief Executive Officer Terig Hughes - Chief Financial Officer Dr. Jake Micallef - Chief Scientific Officer Conference Call Participants Kyle Mikson - Cantor Fitzgerald Jason McCarthy - Maxim Group Nathan Weinstein - Agesi Capital Bruce Jackson - Benchmark Company Operator Good morning, ladies and gentlemen, and thank you for standin ...